• IBB Sant Pau, partner of CARDIOPATCH, organised  an event in Catalonia on the 23th of January to present the project and new developments in the treatment of cardiovascular diseases

• The conference is part of CARDIOPATCH initiatives to bring its advances closer to the rest of society

The Research Institute of the Hospital Santa Creu i Sant Pau (IIB Sant Pau), partner of CARDIOPATCH, organised a new event in Gerona (Catalonia) on the 23th of January within the framework of the project. It was aimed at society and healthcare professionals to present new therapeutic strategies for cardiovascular prevention. 

During the event, Dr. Gemma Vilahur and Dr. Lina Badimon explained to members of the association GICOR, an associate partner of CARDIOPATCH, and other health facilities from the Catalan region the latest developments in research and treatment of cardiovascular diseases.

To this end, they showed the example of the developments of the collaborative European project CARDIOPATCH, co-financed by Interreg Sudoe Programme through the European Regional Development Fund (ERDF), in which the two specialist are involved in the design of an advanced therapy for patients with myocardial infarction.

Through regenerative medicine and 3D printing technologies, the European initiative aims to develop a smart patch capable of regenerating heart tissue affected by a heart attack.

In addition, they presented their work in the task force led by IBB Sant Pau in the project, focused on the analysis of the therapeutic potential of the patches and the choice of the final patch.

The conference held in Catalonia is part of a series of initiatives that seek to reinforce one of CARDIOPATCH’s main objectives: to bring its advances closer to the rest of society and, especially, to the hospital and preventive healthcare community.

Coordinated by the Clínica Universidad de Navarra (CUN), CARDIOPATCH comprises partners from Spain, France and Portugal: CIMA University of Navarra, through the Foundation for Applied Medical Research, the Leartiker Technology Centre, the Foundation Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, the communication agency GUK, Centre Hospitalier Universitaire de Toulouse, the University of Montpellier (UM) - Institut des Biomolécules Max Mousseron (IBMM), GenIbet Biopharmaceuticals and the Institute of Experimental and Technological Biology.